OOIR: Observatory of International Research

Papers

(The H4-Index of Circulation-Arrhythmia and Electrophysiology is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Discrimination Between Anterior and Posterior Left Atrial Roof Area Ablation by a Cryoballoon	184
Long-Term Risk Assessment in Athletes With Complex Ventricular Arrhythmias	156
The Science Behind the Standardization of Chest Protectors: Is Marketing Alone Enough to Sell Chest Protectors?... Not Anymore!	127
Impact of Baseline Left Atrial Size on Outcomes Following Catheter Ablation for AF in Patients With Left Ventricular Systolic Dysfunction	97
Myocarditis and Sudden Cardiac Death in the Community: Clinical and Pathological Insights From a National Registry in the United Kingdom	96
Inappropriate Shock Rates and Long-Term Complications due to Subcutaneous Implantable Cardioverter Defibrillators in Patients With and Without Heart Failure: Results From a Multicenter, International	85
Engineering of Generative Artificial Intelligence and Natural Language Processing Models to Accurately Identify Arrhythmia Recurrence	85
Identification of Circumferential Pulmonary Vein Isolation Gaps and Critical Atrial Substrate From HD Grid Maps in Atrial Fibrillation Patients: Insights From Omnipolar Technology	81
Athlete’s Heart or Heart at Risk? Cardiac Remodeling and Exercise-Induced Ventricular Arrhythmias in Elite Athletes	72
Intraoperative Ventricular Tachycardia Ablation During Left Ventricular Assist Device Implantation in High-Risk Heart Failure Patients	72
Multicenter Prospective Randomized Study Comparing the Incidence of Periprocedural Cerebral Embolisms Caused by Catheter Ablation of Atrial Fibrillation Between Cryoballoon and Radiofrequency Ablation	72
4D Digital Heart Model–Guided Left and Right Ventricular Lead Placement for Cardiac Resynchronization Therapy: Results of MAPIT-CRT Trial	66
Risk Factors for the Development of New-Onset Persistent Atrial Fibrillation: Subanalysis of the VITAL Study	65
Learning Before Burning: Mapping With Reversible Pulsed Field Ablation	64
Tetralogy of Fallot: A Long Journey but Getting Closer to Perfection	63
GENESIS: Gene-Specific Machine Learning Models for Variants of Uncertain Significance Found in Catecholaminergic Polymorphic Ventricular Tachycardia and Long QT Syndrome-Associated Genes	60
Convolutional Neural Network Models Leverage Morphological Rather Than Temporal Features to Detect Myocardial Diseases From 12-Lead Electrocardiograms	60
CKAP4 Promotes Atrial Fibrosis and Enhances Atrial Fibrillation Vulnerability via WNT/β-Catenin Activation	59
Left Atrial Thrombus Occurring in Sinus Rhythm: Role of Variants of the Atrial Septum	58
Nonsustained Ventricular Tachycardia Is Independently Associated With Sustained Ventricular Arrhythmias in Nonischemic Dilated Cardiomyopathy	54
Magnetic Resonance Imaging in the Assessment of the Risk of Sudden Death in Cardiac Sarcoidosis: What Is Extensive or Significant Late Gadolinium Enhancement?	54
Correction to: Orthostatic Hypotension: Management of a Complex, But Common, Medical Problem	53
Scar Voltage Mapping in Fast Ventricular Tachycardia for Identifying Functional Substrates of Tachycardia Isthmuses: A Proof-of-Concept Study	53
Correction to: Gagyi et al, New Possibilities in the Treatment of Brief Episodes of Highly Symptomatic Atrial Tachycardia: The Usefulness of Single-Position Single-Beat Charge Density Mapping	45
Stroke Mortality in Patients With Atrial Fibrillation/Flutter: Overall Trends and Sex Differences in the United States	44

Transesophageal Echocardiography Following Left Atrial Appendage Electrical Isolation: Diagnostic Pitfalls and Clinical Implications	43
Voltage Map Guided Nonocclusive Balloon Cryoablation to Achieve Antral Pulmonary Vein Isolation	43
Economic and Health Value of Delaying Atrial Fibrillation Progression Using Radiofrequency Catheter Ablation	41
Artificial Sweeteners: A New Dietary Environmental Risk Factor for Atrial Fibrillation?	41
Multicenter, Phase 2, Randomized Controlled Study of the Efficacy and Safety of Etripamil Nasal Spray for the Acute Reduction of Rapid Ventricular Rate in Patients With Symptomatic Atrial Fibrillation	39
Physiologic Effects of Right-Sided Intravascular Cervical Sympathetic Nerve Stimulation	37
Predictors of Response to Cardiac Resynchronization Therapy in Pediatric Patients and Patients With Congenital Heart Disease	36
Higher Daily Temperature Is Associated With Prolonged Device-Detected Atrial Fibrillation Episodes	35